Tiziana Life Sciences Ltd (NASDAQ:TLSA) is a clinical-stage biotech company focused on next-generation immunomodulation ...
Alterity Therapeutics has shown its Multiple System Atrophy drug ATH-434 has a potential market value of US$2.4 billion if ...
The latest announcement is out from Alterity Therapeutics ( (AU:ATH) ).
After menopause, women with MS show accelerated loss of volume in brain structures associated with memory, attention, and problem-solving.
CurePSP announced that its network of Centers of Care has grown to 38 institutions with the addition of the University of Colorado Anschutz Medical Campus, University of Texas Health Science Center at ...
MedPage Today on MSN
Case Study: What Is Causing Blurry Vision Followed by a Cascade of Symptoms in a Young Woman?
As they explained in their case report in the Journal of Neurology and Neuroscience, ophthalmologic examination identified ...
The ASX closed 0.16% lower on September 30, 2025 after the RBA kept the cash rate on hold at 3.6% at its latest meeting.
See why Teva Pharmaceutical Industries Limited is shifting the CNS market with Austedo sales growth, new clinical data, and ...
Explore the Fight Retinal Blindness! Project, a global registry enhancing VEGF inhibitor treatment outcomes with ...
The human body requires protein as one of its fundamental nutritional elements, and it is known as the 'building block of the ...
A children's social worker remembers their former team manager, who was instrumental in supporting her team during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback